Program Management Update

Source: RNS
RNS Number : 9554M
R&Q Insurance Holdings Ltd
17 January 2023
 

Logo Description automatically generated

 

R&Q Insurance Holdings Ltd

 

Program Management Update

 

Seven new programs added during December

 

17 January 2023

 

R&Q Insurance Holdings Ltd, (AIM-RQIH) ("R&Q"), the leading non-life global specialty insurance company focusing on Program Management and Legacy Insurance businesses, is pleased to announce an update for its Program Management business.

 

R&Q Accredited approved partnerships with seven new programs in December 2022. These programs will begin writing business over the course of the first quarter of 2023, with an anticipated total Gross Written Premium ('GWP') of ~$130 million over next 12-15 months.

 

The new programs include:

·    Expanding existing partnerships for Accredited America with three new programs with Falvey Insurance Group and one with Southern Star MGA

·      New program partnerships for Accredited America with Platinum Specialty Underwriters, LLC and Cover Whale

·      New program partnership for Accredited Europe with for broker GmbH, its first MGA partner in Germany

 

William Spiegel, Executive Group Chairman, commented:

 

"Our Program Management business ended 2022 with a flurry of activity as we approved and began onboarding a number of new programs. We continue focusing on diversifying our business while also deepening our relationships with existing partners. It is exciting to see our growth being delivered across our three platforms (US Admitted, US Non-Admitted, and Europe) including our first program partnership in Germany. In 2023 we will see continued growth from our existing partners as well as the onboarding of further new MGAs. Our pipeline remains strong and we believe we are well placed as a partner of choice for leading MGAs in the US, UK and Europe."

 

R&Q expects to issue its full Q4 Program Update in February. 

 

Ends

 



Enquiries to:

 

R&Q Insurance Holdings Ltd


William Spiegel

Tel: 0207 780 5850

Tom Solomon   

Tel: 0207 780 5850

 

Numis Securities Limited (Nominated Advisor and Joint Broker)

Giles Rolls 

Tel: 020 7260 1000

Charles Farquhar 

 

Barclays Bank PLC (Joint Broker)

Andrew Tusa

Richard Bassingthwaighte

Tel: 020 7260 1000

 

 

Tel: 020 7632 2322

 



FTI Consulting

Tom Blackwell / Shipra Khanna

 

Tel: 020 3727 1051

 

 

 




Notes to Editors:

 

About R&Q 

 

R&Q is a global non-life specialty insurance company. We operate two core, highly complementary, businesses: Program Management and Legacy Insurance. Both these businesses are leaders in their respective markets.

 

Our approach is to deploy our origination and underwriting capabilities, alongside our licensed and rated carriers in the US, EU, and the UK, to generate attractive fee returns in Program Management and Legacy Insurance.

 

Legal Entity Identifier (LEI): 2138006K1U38QCGLFC94

 

Website: www.rqih.com

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAFIFLRLIIDLIV